163 related articles for article (PubMed ID: 38162062)
21. miR-33a-5p enhances the sensitivity of lung adenocarcinoma cells to celastrol by regulating mTOR signaling.
Li YJ; Sun YX; Hao RM; Wu P; Zhang LJ; Ma X; Ma Y; Wang PY; Xie N; Xie SY; Chen W
Int J Oncol; 2018 Apr; 52(4):1328-1338. PubMed ID: 29484434
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of petasin on human colon carcinoma cells mediated by inactivation of Akt/mTOR pathway.
Lyu X; Song AL; Bai YL; Xu XD; He DQ; Zhang YC
Chin Med J (Engl); 2019 May; 132(9):1071-1078. PubMed ID: 30896562
[TBL] [Abstract][Full Text] [Related]
23. The isoflavone puerarin exerts anti-tumor activity in pancreatic ductal adenocarcinoma by suppressing mTOR-mediated glucose metabolism.
Zhu H; Xiao Y; Guo H; Guo Y; Huang Y; Shan Y; Bai Y; Lin X; Lu H
Aging (Albany NY); 2021 Dec; 13(23):25089-25105. PubMed ID: 34863080
[TBL] [Abstract][Full Text] [Related]
24. Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.
Aroor AR; Das NA; Carpenter AJ; Habibi J; Jia G; Ramirez-Perez FI; Martinez-Lemus L; Manrique-Acevedo CM; Hayden MR; Duta C; Nistala R; Mayoux E; Padilla J; Chandrasekar B; DeMarco VG
Cardiovasc Diabetol; 2018 Jul; 17(1):108. PubMed ID: 30060748
[TBL] [Abstract][Full Text] [Related]
25. [Effects of Xihuang Pills on proliferation and apoptosis of prostate cancer LNCaP cells based on AR/m TOR signaling pathway].
Dai XJ; Long Y; Zou B; Wu LT; Qiu JF; Wu YR; Deng Z; Wang YL; Zhou Q; Tian XF
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(15):4147-4155. PubMed ID: 37802783
[TBL] [Abstract][Full Text] [Related]
26. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
27. Anti-Cancer Effects of Radix Angelica Sinensis (Danggui) and N-Butylidenephthalide on Gastric Cancer: Implications for REDD1 Activation and mTOR Inhibition.
Liao KF; Chiu TL; Huang SY; Hsieh TF; Chang SF; Ruan JW; Chen SP; Pang CY; Chiu SC
Cell Physiol Biochem; 2018; 48(6):2231-2246. PubMed ID: 30114701
[TBL] [Abstract][Full Text] [Related]
28. Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma.
Hansel DE; Platt E; Orloff M; Harwalker J; Sethu S; Hicks JL; De Marzo A; Steinle RE; Hsi ED; Theodorescu D; Ching CB; Eng C
Am J Pathol; 2010 Jun; 176(6):3062-72. PubMed ID: 20395440
[TBL] [Abstract][Full Text] [Related]
29. Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer.
Xu DZ; Geng QR; Tian Y; Cai MY; Fang XJ; Zhan YQ; Zhou ZW; Li W; Chen YB; Sun XW; Guan YX; Li YF; Lin TY
BMC Cancer; 2010 Oct; 10():536. PubMed ID: 20929525
[TBL] [Abstract][Full Text] [Related]
30. Extract of
Cui XL; Li KJ; Ren HX; Zhang YJ; Liu XD; Bu BG; Wang L
World J Gastroenterol; 2019 Apr; 25(15):1854-1864. PubMed ID: 31057299
[TBL] [Abstract][Full Text] [Related]
31. Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling.
Abdelkader NF; Elbaset MA; Moustafa PE; Ibrahim SM
Arch Pharm Res; 2022 Jul; 45(7):475-493. PubMed ID: 35767208
[TBL] [Abstract][Full Text] [Related]
32. Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na
Uthman L; Baartscheer A; Bleijlevens B; Schumacher CA; Fiolet JWT; Koeman A; Jancev M; Hollmann MW; Weber NC; Coronel R; Zuurbier CJ
Diabetologia; 2018 Mar; 61(3):722-726. PubMed ID: 29197997
[TBL] [Abstract][Full Text] [Related]
33. Can we go beyond surrogates?
Drexler A
J Diabetes; 2017 Nov; 9(11):976-977. PubMed ID: 28692750
[TBL] [Abstract][Full Text] [Related]
34.
Qian Y; Yan Y; Lu H; Zhou T; Lv M; Fang C; Hou J; Li W; Chen X; Sun H; Li Y; Wang Z; Zhao N; Gu Y; Ding Y; Liu Y
Anticancer Agents Med Chem; 2019; 19(14):1754-1761. PubMed ID: 31364518
[TBL] [Abstract][Full Text] [Related]
35. Rab1A knockdown represses proliferation and promotes apoptosis in gastric cancer cells by inhibition of mTOR/p70S6K pathway.
Li Z; Li Y; Jia Y; Ding B; Yu J
Arch Biochem Biophys; 2020 May; 685():108352. PubMed ID: 32240637
[TBL] [Abstract][Full Text] [Related]
36. SGLT2 inhibitor-empagliflozin treatment ameliorates diabetic retinopathy manifestations and exerts protective effects associated with augmenting branched chain amino acids catabolism and transportation in db/db mice.
Gong Q; Zhang R; Wei F; Fang J; Zhang J; Sun J; Sun Q; Wang H
Biomed Pharmacother; 2022 Aug; 152():113222. PubMed ID: 35671581
[TBL] [Abstract][Full Text] [Related]
37. 18β-glycyrrhetinic acid regulates mitochondrial ribosomal protein L35-associated apoptosis signaling pathways to inhibit proliferation of gastric carcinoma cells.
Yuan L; Yang Y; Li X; Zhou X; Du YH; Liu WJ; Zhang L; Yu L; Ma TT; Li JX; Chen Y; Nan Y
World J Gastroenterol; 2022 Jun; 28(22):2437-2456. PubMed ID: 35979263
[TBL] [Abstract][Full Text] [Related]
38. Combining molecular targeted drugs to inhibit both cancer cells and activated stromal cells in gastric cancer.
Onoyama M; Kitadai Y; Tanaka Y; Yuge R; Shinagawa K; Tanaka S; Yasui W; Chayama K
Neoplasia; 2013 Dec; 15(12):1391-9. PubMed ID: 24403861
[TBL] [Abstract][Full Text] [Related]
39. Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo.
Chen M; Huang SL; Zhang XQ; Zhang B; Zhu H; Yang VW; Zou XP
J Cell Biochem; 2012 Jul; 113(7):2474-87. PubMed ID: 22396185
[TBL] [Abstract][Full Text] [Related]
40. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
Wang C; Gao D; Guo K; Kang X; Jiang K; Sun C; Li Y; Sun L; Shu H; Jin G; Sun H; Wu W; Liu Y
BMC Cancer; 2012 May; 12():166. PubMed ID: 22559167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
